Literature DB >> 27119161

A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.

Kamila Domińska1, Tomasz Ochędalski2, Karolina Kowalska2, Zuzanna E Matysiak-Burzyńska2, Elżbieta Płuciennik3, Agnieszka W Piastowska-Ciesielska2.   

Abstract

The prostate gland is a part of the male reproductive tract which produces both angiotensin II (Ang II) and relaxin 2 (RLN2). The present study analyzes the effect of both these peptide hormones at concentration 10(-8)M on viability, proliferation, adhesion, migration, and invasion of normal prostate epithelial cells (PNT1A). Improved survival in two- and three-dimensional cell cultures was noted as well as visual changes in colony size and structure in Geltrex™. Stimulatory influence on cell viability of each peptide applied single was lower than in combination. Enhanced survival of PNT1A cells appears to be associated with increased BCL2/BAX messenger RNA (mRNA) expression ratio. Modulation of cell spreading and cell-extracellular matrix adhesion dynamics were also altered as an influence of tested hormone application. However, long-term Ang II and RLN2 effects may lead to an increase of normal prostate cell migration and invasion abilities. Moreover, gelatin zymography revealed that both gelatinases A and B were augmented by Ang II treatment, whereas RLN2 significantly stimulated only MMP-9 secretion. These results support the hypothesis that deregulation of locally secreted peptide hormones such as Ang II and RLN2 may take part in the development of certain cancers, including prostate cancer. Moreover, the observed ability of relaxin 2 to act as a regulator of mRNA expression levels not only LGR7 but also classic angiotensin receptors suggested that renin-angiotensin system and relaxin family peptide system are functionally linked.

Entities:  

Keywords:  Angiotensin II; PNT1A; Peptide hormones, prostate gland; Relaxin 2

Mesh:

Substances:

Year:  2016        PMID: 27119161     DOI: 10.1007/s13105-016-0489-1

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  38 in total

Review 1.  Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: review and protocols.

Authors:  Wilma M Frederiks; Olaf R F Mook
Journal:  J Histochem Cytochem       Date:  2004-06       Impact factor: 2.479

Review 2.  Nuclear shape, mechanics, and mechanotransduction.

Authors:  Kris Noel Dahl; Alexandre J S Ribeiro; Jan Lammerding
Journal:  Circ Res       Date:  2008-06-06       Impact factor: 17.367

Review 3.  The renin-angiotensin system and male reproduction: new functions for old hormones.

Authors:  P S Leung; C Sernia
Journal:  J Mol Endocrinol       Date:  2003-06       Impact factor: 5.098

Review 4.  [Relaxin 2--a pregnancy hormone involved in the process of carcinogenesis].

Authors:  Kamila Domińska
Journal:  Ginekol Pol       Date:  2013-02       Impact factor: 1.232

Review 5.  Molecular pathogenesis and progression of prostate cancer.

Authors:  Randy Schrecengost; Karen E Knudsen
Journal:  Semin Oncol       Date:  2013-06       Impact factor: 4.929

6.  Phenotypic and genotypic characterization of commonly used human prostatic cell lines.

Authors:  S Mitchell; P Abel; M Ware; G Stamp; E Lalani
Journal:  BJU Int       Date:  2000-05       Impact factor: 5.588

7.  Breast cancer relapse prediction based on multi-gene RT-PCR algorithm.

Authors:  Elzbieta Pluciennik; Maciej Krol; Magdalena Nowakowska; Renata Kusinska; Piotr Potemski; Radzislaw Kordek; Andrzej K Bednarek
Journal:  Med Sci Monit       Date:  2010-03

Review 8.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

Review 9.  Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.

Authors:  Elin Hadler-Olsen; Jan-Olof Winberg; Lars Uhlin-Hansen
Journal:  Tumour Biol       Date:  2013-05-17

10.  High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.

Authors:  Vesa Hongisto; Sandra Jernström; Vidal Fey; John-Patrick Mpindi; Kristine Kleivi Sahlberg; Olli Kallioniemi; Merja Perälä
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more
  4 in total

1.  Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.

Authors:  Deborah A Howatt; Maya Dajee; Xiaojie Xie; Jessica Moorleghen; Debra L Rateri; Anju Balakrishnan; Valdeci Da Cunha; Douglas G Johns; David E Gutstein; Alan Daugherty; Hong Lu
Journal:  Circ J       Date:  2017-04-18       Impact factor: 2.993

Review 2.  Relaxin-like peptides in male reproduction - a human perspective.

Authors:  Richard Ivell; Alexander I Agoulnik; Ravinder Anand-Ivell
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

3.  Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.

Authors:  Aino Siltari; Teemu J Murtola; Kirsi Talala; Kimmo Taari; Teuvo L J Tammela; Anssi Auvinen
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

Review 4.  The Effect of Local Renin Angiotensin System in the Common Types of Cancer.

Authors:  Moudhi Almutlaq; Abir Abdullah Alamro; Hassan S Alamri; Amani Ahmed Alghamdi; Tlili Barhoumi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-03       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.